SEC Form 4 reporting owner

Lyssikatos Joseph P

Lyssikatos Joseph P has filed 10 Form 4 transactions reported between December 19, 2025 and February 12, 2026, as CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics, Inc..

Name as filed: Lyssikatos Joseph P

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.2M
8 lines
Companies
1
with Form 4 filings
Latest transaction
Feb 12, 2026
transaction date

Roles and reported holdings

  • ELVNEnliven Therapeutics, Inc.
    Dec 19, 2025 – Feb 12, 2026

    CHIEF SCIENTIFIC OFFICER

    Held indirectly (latest line)740,188 sh as of Feb 6, 2026 · Form 4

    24 months: $4.2M sold

Transaction history

All 10 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Feb 12, 2026ELVNCHIEF SCIENTIFIC OFFICERGrant or awardCode A · direct112,500—Form 4
Feb 12, 2026ELVNCHIEF SCIENTIFIC OFFICERGrant or awardCode A · direct18,750—Form 4
Feb 6, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect5,000$145K@ $29.04Form 4
Jan 20, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect14,509$390K@ $26.90Form 4
Jan 20, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect5,491$145K@ $26.37Form 4
Jan 9, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect50,000$1.5M@ $29.13Form 4
Jan 9, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect41,198$1.0M@ $24.90Form 4
Jan 8, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect33,802$842K@ $24.92Form 4
Jan 8, 2026ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect7,500$151K@ $20.13Form 4
Dec 19, 2025ELVNCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · indirect5,000$84K@ $16.84Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.